About
Porosome Therapeutics develops therapies based on the discovery and structural study of the porosome, a cellular secretory nanomachine, targeting diseases such as Alzheimer's, cystic fibrosis, and diabetes by correcting secretory defects using AI-enabled precision drug development.
Explore Porosome Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.